cell-therapy-for-all-stem-cell Videos
35 videos found
TreeFrog Therapeutics is a stem cell company based in Bordeaux, France, that will enable millions of patients to access the medical revolution of cell therapy by overcoming its main manufacturing ...
Jul. 13, 2022
In laying the groundwork for the future of cell therapies, CMaT engages a diverse range of stakeholders worldwide, from various backgrounds, and with distinct perspectives. ...
Jun. 2, 2022
We have human Trophoblast Stem Cells. Contact us for collaboration for new cell ...
Jun. 3, 2022
Oct. 10, 2022
Dr. Amish Raval of the University of Wisconsin - Madison talks about the CardiAMP cell therapy and the pivotal phase III CardiAMP Heart Failure ...
May. 31, 2022
Over the past decade, Adaptive has developed our proprietary immune medicine platform to read and translate the adaptive immune system at scale and with precision to use its capabilities in the clinic. ...
Oct. 10, 2022
A quick overview of C-Stem™, the patented technology operated by TreeFrog Therapeutics to mass-produce stem cells for cell ...
Jul. 13, 2022
The Electrospinning Company Ltd. are a contract development manufacturing organisation. Operating under ISO 13485 guidance, we offer a complete end-to-end services to take your innovation from concept to ...
May. 8, 2021
Rethink Cell Therapy with Lipid Nanoparticles. Available April 16, 2021 The GenVoy-ILM T Cell Kit for mRNA is an LNP reagent mix optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr® Spark™ instrument and cartridges. It can be used at various stages of cell therapy research and development from discovery to ...
Oct. 5, 2021
Carina Biotech and AdAlta are collaborating to develop precision engineered CAR-T cell therapies that provide new hope for patients. AdAlta and Carina Biotech experts; Dr Deborah Rathjen, Carina Biotech CEO & Managing Director, Dr Tim Oldham, AdAlta CEO & Managing Director, Professor Shaun McColl, Vice President Chemokine Platform Technology at Carina Biotech, and Michael Foley PhD, AdAlta Chief ...
Feb. 14, 2023
Carina Biotech and AdAlta are collaborating to develop precision engineered CAR-T cell therapies that provide new hope for patients. AdAlta and Carina Biotech experts; Dr Deborah Rathjen, Carina Biotech CEO & Managing Director, Dr Tim Oldham, AdAlta CEO & Managing Director, Professor Shaun McColl, Vice President Chemokine Platform Technology at Carina Biotech, and Michael Foley PhD, AdAlta Chief ...
Jun. 3, 2022
Educational video about ischemic heart failure, current treatment options, and the potential of cell therapy as an alternative treatment option for ...
May. 31, 2022
The adaptive immune system is a force inside your body so powerful it’s able to detect disease and fight it, often before you even realize that you’re ...
Oct. 10, 2022
An instructive whiteboard video explaining how spinal cord injury disrupts normal bodily function as well as OPC1 administration and mechanism of ...
Jul. 15, 2022
At our Research facility in the UK, near Oxford, teams are working to design and develop our next generation cell therapy products to treat patients with cancer. ...
May. 6, 2021